vanoxerine has been researched along with 1-methyl-4-phenylpyridinium in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, JB; Hofsteede, RM; Tuntler, J; Westerink, BH | 1 |
| Carlsson, A; Ekman, A; Engel, J; Magnusson, T; Pileblad, E; Snape, BM | 1 |
| Brossi, A; Chiueh, CC; Gessner, W; Johannessen, JN; Namura, I; Singhaniyom, W; Sun, CJ | 1 |
| Damsma, G; de Vries, JB; Rollema, H; Tuntler, J; Westerink, BH | 1 |
| Corsini, GU; Fascetti, F; Fornai, F; Maggio, R; Vaglini, F | 1 |
| Carlsson, A; Kujacic, M | 1 |
| Pai, KS; Ravindranath, V; Sriram, K | 1 |
| Cavalletti, M; Corsini, GU; Fascetti, F; Fornai, F; Tedeschi, D; Vaglini, F | 1 |
| Centeno, F; Clemente, N; Fuentes, JM; González-Polo, RA; Mora, A; Sabio, G; Soler, G | 1 |
| Mitsumoto, Y; Mori, A; Nakai, M; Watanabe, A | 1 |
| Hillard, CJ; Kalyanaraman, B; Shang, T; Uihlein, AV; Van Asten, J | 1 |
| Matsubara, K; Ohtaki, K; Shimizu, K; Shiono, H | 1 |
| Beach, JW; Collins, MA; Gearhart, DA; Hwang, YI; Neafsey, EJ; Schwarz, J; Storch, A | 1 |
| Bringmann, G; Brückner, R; Feineis, D; Hwang, YI; Ott, S; Schwarz, J; Storch, A | 1 |
| Fujibayashi, Y; Maruoka, N; Murata, T; Omata, N; Takashima, Y; Wada, Y | 1 |
| Calhau, C; Dueñas, M; Faria, A; Gonzalez-Manzano, S; Mateus, N; Meireles, M; Moura, E; Santos-Buelga, C; Vieira-Coelho, MA | 1 |
16 other study(ies) available for vanoxerine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Calcium; Corpus Striatum; Dialysis; Dopamine; Glutamates; Glutamic Acid; Haloperidol; Magnesium; Male; Nomifensine; Ouabain; Piperazines; Potassium; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tetrodotoxin | 1989 |
The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Calcium; Corpus Striatum; Dopamine; In Vitro Techniques; Male; Neurotoxins; Neurotransmitter Uptake Inhibitors; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Reserpine; Time Factors | 1988 |
Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.
Topics: 1-Methyl-4-phenylpyridinium; Amphetamines; Animals; Apomorphine; Corpus Striatum; Dopamine; Male; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra | 1988 |
The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Homovanillic Acid; Male; Morphine; Neurotoxins; Nucleus Accumbens; Piperazines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Septal Nuclei; Tetrodotoxin | 1987 |
(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Ditiocarb; Dizocilpine Maleate; Dopamine; Drug Synergism; Haplorhini; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Piperazines; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats.
Topics: 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Behavior, Animal; Carrier Proteins; Catecholamines; Catechols; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Heart; Injections, Subcutaneous; Male; Membrane Glycoproteins; Membrane Transport Proteins; Myocardium; Nerve Tissue Proteins; Piperazines; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
Protection and potentiation of 1-methyl-4-phenylpyridinium-induced toxicity by cytochrome P450 inhibitors and inducer may be due to the altered uptake of the toxin.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Brain; In Vitro Techniques; Male; Mice; Monoamine Oxidase Inhibitors; Phenobarbital; Piperazines; Piperonyl Butoxide; Proadifen | 1995 |
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetaldehyde; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Ditiocarb; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nicotine; Piperazines; Selegiline; Serotonin | 1996 |
Mechanisms of MPP(+) incorporation into cerebellar granule cells.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acid Transport Systems, Basic; Amino Acids, Basic; Animals; Animals, Newborn; Apoptosis; Carrier Proteins; Cells, Cultured; Cerebellar Cortex; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Herbicides; Male; Membrane Glycoproteins; Membrane Transport Proteins; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Neurotoxins; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2001 |
1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Benzimidazoles; Carbocyanines; Coloring Agents; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluorometry; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Mitochondria; Nerve Tissue Proteins; Oxazines; Oxidation-Reduction; Parkinsonian Disorders; Piperazines; Presynaptic Terminals; Rats; Rats, Wistar; Sodium Cyanide; Synaptosomes; Tyrosine 3-Monooxygenase; Xanthenes | 2003 |
1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3.
Topics: 1-Methyl-4-phenylpyridinium; Adrenergic Uptake Inhibitors; Animals; Anti-Inflammatory Agents; Biological Transport; Cell Survival; Cells, Cultured; Cerebellum; Corticosterone; Desipramine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Estradiol; Female; Male; Neurons; Neuroprotective Agents; Organic Cation Transport Proteins; Piperazines; Quinolines; Rats; RNA, Messenger; Rotenone; Temperature | 2003 |
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Animals, Newborn; Azepines; Cabergoline; Caspases; Cell Count; Cycloheximide; Dizocilpine Maleate; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ergolines; Excitatory Amino Acid Antagonists; Herbicides; Immunohistochemistry; Mesencephalon; NADPH Dehydrogenase; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Organ Culture Techniques; Paraquat; Piperazines; Protein Synthesis Inhibitors; Quinoxalines; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 2003 |
Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Carbolines; Cell Line; Cell Survival; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Harmaline; Harmine; Humans; Inhibitory Concentration 50; Kidney; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methylation; Nerve Tissue Proteins; Parkinson Disease, Secondary; Piperazines | 2004 |
Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain Neoplasms; Carbolines; Cell Line, Tumor; Cell Survival; Data Interpretation, Statistical; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Humans; Mice; MPTP Poisoning; Neuroblastoma; Neurons; Piperazines | 2006 |
Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Autoradiography; Brain Chemistry; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Electron Transport; Fluorodeoxyglucose F18; Glucose; In Vitro Techniques; Male; Models, Neurological; Models, Statistical; Oxidation-Reduction; Piperazines; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar | 2007 |
Flavonoids as dopaminergic neuromodulators.
Topics: 1-Methyl-4-phenylpyridinium; Cations; Cell Line; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Flavonoids; Humans; Neurons; Neurotransmitter Agents; Piperazines; Signal Transduction | 2016 |